Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-017789-22Phase 2Completed
Phase 2, randomised trial in Retinal Microvascular Disease comparing Moxaverine hydrochloride oral with Placebo oral (2 arms). Primary endpoints: Choroidal blood flow and Optic nerve head blood flow. Started Apr 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-017789-22.